UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 27, 2026
Sale
Calculated transaction value
$510.59K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 27, 2026
Public filing date
Jul 28, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$527.94
Jul 27, 2026
Close before public filing
$527.94
Jul 27, 2026
Return since public filing
-5.84%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 957 shares @ $533.53
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000107
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.33M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $814K |
| United Therapeutics Corp UTHR | Exercise | Jul 27, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $594.67K |
| United Therapeutics Corp UTHR | Exercise | Jul 27, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $469.15K |
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $976.11K |
| United Therapeutics Corp UTHR Current | Sale | Jul 27, 2026 | $510.59K |
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $357.55K |
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $343.53K |
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $951.96K |
| United Therapeutics Corp UTHR | Sale | Jul 27, 2026 | $21.4K |